The ADAPTION trial is an investigator initiated prospective randomized doubleblind cross-over pilot study in a multi-center setting. Aim: to assess the ability of minute ventilation (MV) sensor driven rate adaptive atrial stimulation to restore functional capacity and quality of life in heart failure patients with chronotropic incompetence. Methods: heart failure patients (left ventricular ejection fraction ≤35% \& New York Heart Assessment II or III) who were implanted with a 2-chamber implantable cardioverter defibrillator (ICD) device equipped with a MV sensor that are diagnosed with chronotropic incompetence will be included in the study. Patients will be randomized in a 1:1 fashion to rate responsive pacing (MV sensor only) function ON (AAIR mode) or OFF (DDI mode). After 3 months the pacing mode will be switched to the opposite mode.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
65
Rate adaptive pacing using a MV sensor.
Rate adaptive pacing OFF
VU university medical center
Amsterdam, Netherlands
RECRUITINGImprovement of quality of life
Measured with the Minnesota Living with Heart Failure Questionnaire
Time frame: 3 months after changing the pacing mode
Improvement of functional capacity
Measured with a six-minute walk test
Time frame: 3 months after changing the pacing mode
Reversibility of chronotropic incompetence
A comparison of the modified HeartRateScore with and without rate adaptive pacing.
Time frame: 3 months after changing the pacing mode
Clinical status
Measured with NYHA class assessment and number of hospitalizations for heart failure.
Time frame: 3 months after changing the pacing mode
Daily activity level
Measured with the device's accelerometer
Time frame: 3 months after changing the pacing mode
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.